News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major headlines were published in the past hour.
  • Major global indices were little changed as traders awaited new catalysts.
  • No economic data releases or central bank comments occurred in the past hour.
  • No significant geopolitical events or policy announcements were reported.
  • Trading volume and volatility stayed low ahead of upcoming sessions.

Latest Articles

Victoria’s Secret & Co. Reports Second Quarter 2026 Results

Victoria’s Secret & Co. Reports Second Quarter 2026 Results

Victoria's Secret & Co. reported a strong second quarter in 2026 with net sales increasing 10% to $1.611 billion, operating income rising to $257 million, and adjusted operating income surpassing guidance at $124 million. The company has raised its full-year 2026 net sales and adjusted operating income guidance, citing growth across all business se…

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics announced its participation in several upcoming investor conferences, including the Cantor Global Healthcare Conference and Morgan Stanley Annual Global Healthcare Conference. The company focuses on developing IL-1β pathway therapeutics for immune-mediated inflammatory diseases and is advancing its lead candidate, abdakibart, int…

ANI Pharmaceuticals to Present at September Investor Conferences

ANI Pharmaceuticals to Present at September Investor Conferences

ANI Pharmaceuticals announced its participation in three upcoming investor conferences in September 2026, where its CEO and leadership team will present and engage in discussions. The conferences include the Wells Fargo Healthcare Conference, Morgan Stanley Global Healthcare Conference, and H.C. Wainwright Annual Global Investment Conference. These…

Lands’ End Announces Second Quarter Fiscal 2026 Results

Lands’ End Announces Second Quarter Fiscal 2026 Results

Lands' End, Inc. (NASDAQ: LE) announced second quarter fiscal 2026 results highlighting a 2.7% increase in net revenue to $302 million driven by a 9% rise in U.S. eCommerce sales. The company reported net income of $3.5 million versus a loss in the prior year period, with gross margins improving by 320 basis points due in part to tariff refunds. Op…

Legrand Shares Rise After Dual Analyst Upgrades and Strong H1 Results

Legrand Shares Rise After Dual Analyst Upgrades and Strong H1 Results

Legrand shares climbed after Deutsche Bank upgraded the stock to Buy and raised its price target, joining Morgan Stanley which recently named Legrand a Top Pick and also lifted its target. Analysts pointed to accelerated organic growth and a larger sales mix from data centers, energy transition and digital lifestyles, while the company’s H1 2026 re…

Intercos Shares Slide After Large ABB by L Catterton Vehicle

Intercos Shares Slide After Large ABB by L Catterton Vehicle

Intercos shares fell sharply after private equity firm L Catterton, via its CP7 vehicle, sold roughly 6 million shares - about 6.2% of the company - through an Accelerated Book Build that raised approximately €81 million. The block trade, arranged by UBS, Jefferies and BNP Paribas, increased free float and placed immediate downward pressure on the …

Moderna: A High-Conviction Long Where the Upside Beats the Risk - If the mRNA Pipeline Keeps Delivering

Moderna: A High-Conviction Long Where the Upside Beats the Risk - If the mRNA Pipeline Keeps Delivering

Moderna ($150.81) is expensive on headline multiples - market cap ~$60.2B and price-to-sales ~27 - yet the stock carries asymmetric upside from an expanding mRNA franchise (recent FDA flu approval and oncology momentum). This trade idea takes a disciplined long stance sized for high volatility: entry $150.81, stop $136.00, target $190.00, horizon 1…

S&P Flags Inflated Credit Scores in China’s Onshore Bond Market

S&P Flags Inflated Credit Scores in China’s Onshore Bond Market

S&P Global Ratings warned that China’s onshore bond market shows an unusually high concentration of top-tier credit ratings, including cases where foreign issuers rated below investment grade internationally receive AAA scores when issuing panda bonds. Regulators have begun pressuring rating agencies to rebalance ratings, prompting downgrades and w…

Barclays Urges Caution Into September as Market Headwinds Reappear

Barclays Urges Caution Into September as Market Headwinds Reappear

Barclays strategists are advising investors to reduce risk exposure ahead of September, citing seasonal patterns, softer U.S. activity, and renewed pressure from rates and energy markets. Despite this shorter-term caution, the bank keeps a constructive medium-term stance on equities, pointing to resilient growth, an earnings upcycle and valuations …

S&P Global Flags Risks from Inflated Credit Scores in China’s Bond Market

S&P Global Flags Risks from Inflated Credit Scores in China’s Bond Market

S&P Global Ratings' Asia-Pacific head warned that an unusually high share of Chinese credit bond issuers carry top-tier ratings, creating potential vulnerabilities as foreign borrowers enter the market. The concentration of AAA and AA ratings, contrasted with global assessments for some foreign issuers, has prompted Chinese authorities to press…